Medical Breakthrough Discovered in Oklahoma

We don't smoke marijuana in MuskogeeWe don't take our trips on LSDWe don't burn our draft cards down on Main StreetWe like livin' right, and bein' free... — Merle Haggard, Okie From Muskogee I’m a sucker for outlaw country music, and Merle Haggard has always been one of my favorites. Okie From Muskogee was my first intr You are receiving this email because you subscribed to Outsider Club. [Click here]( to manage your e-mail preferences. [Outsider Club logo] Medical Breakthrough Discovered in Oklahoma [Jimmy Mengel Photo] By [Jimmy Mengel]( Written Jun. 28, 2018 We don't smoke marijuana in MuskogeeWe don't take our trips on LSDWe don't burn our draft cards down on Main StreetWe like livin' right, and bein' free... — Merle Haggard, Okie From Muskogee I’m a sucker for outlaw country music, and Merle Haggard has always been one of my favorites. Okie From Muskogee was my first introduction to the Mighty Merle. I pulled out the old record yesterday, blew off the dust, and spun it on my turntable. My, how the times have changed since then... That song was released in September 1969 — a time when it seemed like conservatives and liberals had absolutely nothing but hatred and contempt for one another (what a difference a few decades make?). The Vietnam War was raging, and the counterculture on the coasts was taking to the streets in droves to protest it. But in Oklahoma, as Merle sang, “We don't let our hair grow long and shaggy, like the hippies out in San Francisco do.” As of this week, Oklahoma and California have at least one thing in common: they have both embraced legal marijuana… [Anonymous Tip Leads to Your Next Six-Figure Payday]( On Tuesday, April 17th, Investment Director Jimmy Mengel found a strange note on his desk… “Marijuana company — you get first look” It led him to one of the most exciting investment opportunities of our lifetimes. A revolutionary pot company on the brink of curing the world’s most deadly and prevalent diseases. And within the next 90 days it’s set to soar as much as 6,236% when it goes public with a “deal” it’s struck with the FDA. [Get in on the ground floor today — click here for the full details.]( Question 788 was approved by the people of Oklahoma by a 57% to 43% margin on Tuesday. That is a major vote for marijuana legalization in a very, very red state. That makes it the 30th state to legalize medical marijuana. Not only did the state begin to allow medical marijuana, it took it one step further. While some other states have passed similar laws, they typically came with a caveat that it could only be used for specific and serious ailments like epilepsy, multiple sclerosis, and PTSD. Oklahoma's new law will allow doctors to recommend medical cannabis for any condition they see fit. That opens up a ton of options for doctors to prescribe cannabis treatments for a variety of other ailments like anxiety, depression, and chronic pain — all of which have evidence for cannabis treatments’ efficacy. I recently interviewed “Pennsylvania’s First Pot Doctor”, Dr. Matthew Roman. He heads up Nature’s Way Medicine in Philadelphia and Wilmington, Delaware. “I have patients who come in to my office that have long lists of medication... and here’s the thing... almost every single one of them can be replaced by cannabis,” he told me. Dr. Roman went on to describe the current pharmaceutical culture that treats ailments like pain with dangerous and addictive drugs like opiates. Sadly, by the time you read this article, someone likely overdosed on these destructive medications. I’ve personally seen it happen too many times over the years... Cannabis treatments are safe, non-addictive, and best of all — revolutionary. Now that the stigma is being lifted we are going to start witnessing one of the biggest breakthroughs in medicine in our lifetime… [Does This Map Unlock the Key to 10-Bagger Gains?]( The map below is of a historic new discovery: an entire new continent! Estimates put its wealth at a stunning $30 TRILLION. That makes it even richer than North America, Asia, and Europe! Now, I’ve identified how to buy in on the ground floor for 1,000% gains (or much higher). This comes on the heels of the FDA’s decision to approve the first medical marijuana drug. Earlier in the week, the agency green-lit GW Pharmaceuticals' (NASDAQ: GWPH) cannabis-based product for treating epilepsy. It’s called Epidiolex. [Like Nick told you yesterday](, Epidiolex only treats two rare forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. And when I say rare, I mean incredibly rare — according to the National Organization for Rare Disorders, Dravet syndrome affects 0.0064% of the population. While it is the first shot fired in the coming arms race for cannabis-based pharmaceuticals, imagine the possibilities for diseases like cancer and pain. I’ve been following a company that could lead the way to a revolution in cannabis-based medicine. It has locked down the vital patents of some major medical breakthroughs for glaucoma, skin disease, and even breast cancer. These breakthroughs could make it a monopoly once the patents clear and the federal regulations are lifted for it to proceed with its life-changing medical developments. Oklahoma's decision this week could help lead the way. [You can see for yourself right here.]( Godspeed, [Jimmy Mengel] Jimmy Mengel [follow basic]( [@mengeled on Twitter]( Jimmy is a managing editor for [Outsider Club]( and the investment director of the personal finance advisory, [The Crow's Nest,](and cannabis stocks advisory, [The Marijuana Manifesto.]( For more on Jimmy, check out his editor's [page](. *Follow Outsider Club on [Facebook]( and [Twitter](. Breaking: This Device Holds the Key to the Next Wave of Technological Breakthrough! This tiny, cutting-edge company makes a component that could hand early investors a 10x, 15x, or even 30x return on their investment. - Facebook is investing in it to handle its $4.5 billion online advertising business. - Amazon just invested $775 million in it to help fill warehouse orders. - Apple just invested a staggering $10.5 billion in it to rapidly assemble iPhones and crank up its supply chain operations to maximum speed. The opportunity this breakthrough technology presents could make you big, fat gains, giving you the chance to turn every $1,000 into $673,000. [Click here for more.]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [FDA Approves Cannabis Drug, More to Come]( [Marijuana Pharmaceuticals: The First (and Smallest) Of Many]( [The Next Major Gold District?]( [Earnings Trouble Around The Corner]( [The Wealth Warrior: A Massive Ground-floor Opportunity]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Outsider Club](, Copyright © 2018, [Angel Publishing LLC]( & Outsider Club LLC, 111 Market Place #720, Baltimore, MD 21202. For Customer Service, please call (877) 303-4529. All rights reserved. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. Angel Publishing and Outsider Club does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. This letter is not intended to meet your specific individual investment needs and it is not tailored to your personal financial situation. Nothing contained herein constitutes, is intended, or deemed to be – either implied or otherwise – investment advice. Neither the publisher nor the editors are registered investment advisors. This letter reflects the personal views and opinions of Nick Hodge and that is all it purports to be. While the information herein is believed to be accurate and reliable it is not guaranteed or implied to be so. Neither Nick Hodge, nor anyone else, accepts any responsibility, or assumes any liability, whatsoever, for any direct, indirect or consequential loss arising from the use of the information in this letter. The information contained herein is subject to change without notice, may become outdated and may not be updated. Nick Hodge, entities that he controls, family, friends, employees, associates, and others may have positions in securities mentioned, or discussed, in this letter. No part of this letter/article may be reproduced, copied, emailed, faxed, or distributed (in any form) without the express written permission of Nick Hodge or the Outsider Club. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law.